Keyword: Antibody-Drug Conjugate (ADC)


Veranova Expands ADC and HPAPI Capabilities in the US

28.06.2024 -

US contract development and manufacturing organization (CDMO) Veranova has initiated an expansion of its antibody-drug conjugate (ADC) and highly potent active...


Genmab Completes Acquisition of ProfoundBio

22.05.2024 -

Genmab has completed its $1.8 billion acquisition of ProfoundBio, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) and...


AstraZeneca to Build $1.5 Billion ADC Production Facility in Singapore

22.05.2024 -

In a move to enhance global supply of its antibody drug conjugates (ADCs) portfolio, AstraZeneca intends to build a $1.5 billion facility in Singapore for the...


Genmab to Acquire ProfoundBio for $1.8 Billion

04.04.2024 -

Danish drugmaker Genmab has agreed to buy privately-owned US biotechnology company ProfoundBio for $1.8 billion. ProfoundBio develops novel ADCs and ADC technologies for...

Chemistry & Life Sciences

A New Standard of Collaboration for the Pharmaceutical Industry

20.03.2024 -

Headquartered in Cramlington, UK, Sterling Pharma Solutions is a contract development and manufacturing organization (CDMO) that provides a range of services to the...